Common Contracts

Contract

Co-Development Agreement • May 5th, 2020 • New York

• Contract Type
  Co-Development Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

EX-10.54 2 c13127exv10w54.htm EXHIBIT 10.54 EXHIBIT 10.54 [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. CO-DEVELOPMENT AGREEMENT BY AND BETWEEN QLT INC. AND RETINAGENIX, LLC DATED AS OF April 4, 2006

CO-DEVELOPMENT AGREEMENT BY AND BETWEEN QLT INC. AND RETINAGENIX, LLC DATED AS OF April 4, 2006

Co-Development Agreement • March 1st, 2011 • QLT Inc/Bc • Pharmaceutical preparations • New York

• Contract Type
  Co-Development Agreement
• Filed
  March 1st, 2011
• Company
  QLT Inc/Bc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AGREEMENT (this “Agreement”) is entered into effective as of April 4, 2006 (the “Effective Date”), between QLT INC. (“QLT”), a British Columbia corporation, with offices at 887 Great Northern Way, Vancouver, British Columbia, Canada V5T 4T5, and RETINAGENIX, LLC (“RGX”), a Washington limited liability company, with offices at 3530 West Laurelhurst Drive N.E., Seattle, Washington, USA 98105.